Is Key Safety Data at Risk in Race for COVID Vaccine?

Spread the love

Grace Lee, MD, professor of pediatric infectious diseases, Lucile Salter Packard Children’s Hospital, Stanford University, Stanford, CA.

William Schaffner, MD, professor, preventive medicine, health policy, infectious diseases, Vanderbilt University Medical Center, Nashville.

Tom Frieden, MD, president and CEO, Resolve to Save Lives, New York City.

Hearing, U.S. Senate Committee on Health, Education, Labor and Pensions: “COVID-19: An Update on the Federal Response,” Sept. 23, 2020.

CDC: Advisory Committee on Immunization Practices meeting webcast, Sept. 22, 2020.

FDA: “Development and Licensure of Vaccines to Prevent COVID-19: Guidance for Industry,” June 2020.

Pfizer, study protocol, phase 1/2/3 SARS-COV-2 RNA vaccine candidates, accessed Sept. 25, 2020.

News release, Pfizer, Sept. 8, 2020.




Source link

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *